A recent study has found that people who use cannabidiol (CBD) experience a range of benefits including better sleep, decreased pain, and increased overall wellness. The study, published in the Journal of Psychopharmacology, involved the use of cannabidiol to treat participants with social anxiety, Post-Traumatic Stress Disorder (PTSD), and Generalized Anxiety Disorder (GAD)
A recent study published in The Journal of Clinical Pharmacology has concluded that participants using cannabidiol (CBD) daily reported an increase in overall wellness. In the study, the participants reported pain reduction, sleep quality, mood enhancement, and a general sense of well-being.Just over two months after Validcare announced preliminary results of a study on the effects of cannabidiol (CBD) on the liver, the company announced a separate report on CBD use among Americans, conducted simultaneously with Cannabis Business Experts (CBE), a consumer market research firm. More than 1,400 CBD users in the U.S. participated in CBE and Validcare’s study on the motivation, use, and benefits of CBD, including 839 users who participated in the liver study. CBE and Validcare research. Researchers examined various user data such as age, gender, weight, amount and frequency of CBD use, perceived effects of cannabinoids on various symptoms, and interactions with other medications such as prescription and over-the-counter drugs, dietary supplements, alcohol, and tobacco. In a press release announcing the report, the CBE said: How does the perception of general well-being change when using CBD? Those who want details will have to buy the report, but Ashley Grace, co-founder of CBE, told Hemp Grower that users reported an improved perception of their personal well-being – in other words, they think their well-being has improved since they started using CBD. I can tell you that the overall effectiveness of CBD in this regard is amazing, said Grace, who was also marketing director for Charlotte’s Web and HempFusion. It allows almost anyone to, if not improve, at least maintain their status. There are very few, if any, observations of CBD users getting worse, which is quite remarkable from a research perspective. The 26-page study is available in PDF format and costs $29,999. Anyone wishing to purchase one should contact Grace directly at [email protected] The following 13 CBD-producing companies sponsored the study: Asterra Labs, Boulder Botanical & Bioscience Labs, Care by Design, CBDistillery, CBD American Shaman, Charlotte’s Web, Columbia Care, Global Widget, HempFusion, Infinite CBD, Kannaway, Medterra CBD and SunMed CBD. All participants in the study had used CBD before, which Grace said the researchers were able to confirm because the users were customers of CBD companies. The researchers also found that the 12.5% CBD users in their dataset accounted for about 33% of sales in this category. While this result doesn’t fit the company rule that 20% of users account for 80% of the volume, Grace finds it amazing. I certainly didn’t think we’d reach the 20% of users who make up 80% of the market, because it’s too new a category to do that, but I was shocked that such a small group of people already make up such a large percentage of the category’s volume, he said. When companies better understand who these customers are, they can work to attract them, Grace said. They may also change their strategies to attract new customers. It’s possible to pursue a strategy of using different forms and doses to try to boost your base among other people who use CBD, he said. Regarding research into the use of CBD with other drugs, Grace said: For example, people who have used alcohol and/or tobacco use CBD differently than people who have not used alcohol or tobacco. So there are variations that are very important to understand when working in these areas, because you may or may not have heavy users in your group. There are just different models that are important for people to understand. Another thing I find really interesting is if you’re a CBD company, how do you start positioning and marketing your products, with professional endorsements or chain releases, …. Messages, even in advertising? In addition to commercial companies that may be interested in acquiring the report, such as. B. existing CBD companies, consumer product suppliers and pharmaceutical suppliers, Grace said FDA agencies may also find the report useful. If they are considering something like dosage, I know they have already received a response from Validcare measurement on safety, but if they are considering further regulation on this issue: If we were to set dosage limits for products containing CBD or something similar, that would be good information to study what people are using and where such a limit would best be drawn, if at all.